These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 24396145)

  • 1. The major facilitative folate transporters solute carrier 19A1 and solute carrier 46A1: biology and role in antifolate chemotherapy of cancer.
    Matherly LH; Wilson MR; Hou Z
    Drug Metab Dispos; 2014 Apr; 42(4):632-49. PubMed ID: 24396145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biology of the major facilitative folate transporters SLC19A1 and SLC46A1.
    Hou Z; Matherly LH
    Curr Top Membr; 2014; 73():175-204. PubMed ID: 24745983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folate transporter dynamics and therapy with classic and tumor-targeted antifolates.
    O'Connor C; Wallace-Povirk A; Ning C; Frühauf J; Tong N; Gangjee A; Matherly LH; Hou Z
    Sci Rep; 2021 Mar; 11(1):6389. PubMed ID: 33737637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The membrane transport and polyglutamation of pralatrexate: a new-generation dihydrofolate reductase inhibitor.
    Visentin M; Unal ES; Zhao R; Goldman ID
    Cancer Chemother Pharmacol; 2013 Sep; 72(3):597-606. PubMed ID: 23881211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human proton-coupled folate transporter: Biology and therapeutic applications to cancer.
    Desmoulin SK; Hou Z; Gangjee A; Matherly LH
    Cancer Biol Ther; 2012 Dec; 13(14):1355-73. PubMed ID: 22954694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced receptor-mediated endocytosis and cytotoxicity of a folic acid-desacetylvinblastine monohydrazide conjugate in a pemetrexed-resistant cell line lacking folate-specific facilitative carriers but with increased folate receptor expression.
    Zhao R; Diop-Bove N; Goldman ID
    Mol Pharmacol; 2014 Feb; 85(2):310-21. PubMed ID: 24249723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proton-coupled folate transporter: impact on pemetrexed transport and on antifolates activities compared with the reduced folate carrier.
    Zhao R; Qiu A; Tsai E; Jansen M; Akabas MH; Goldman ID
    Mol Pharmacol; 2008 Sep; 74(3):854-62. PubMed ID: 18524888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced levels of folate transporters (PCFT and RFC) in membrane lipid rafts result in colonic folate malabsorption in chronic alcoholism.
    Wani NA; Kaur J
    J Cell Physiol; 2011 Mar; 226(3):579-87. PubMed ID: 21069807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A P425R mutation of the proton-coupled folate transporter causing hereditary folate malabsorption produces a highly selective alteration in folate binding.
    Shin DS; Zhao R; Yap EH; Fiser A; Goldman ID
    Am J Physiol Cell Physiol; 2012 May; 302(9):C1405-12. PubMed ID: 22345511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional loss of the reduced folate carrier enhances the antitumor activities of novel antifolates with selective uptake by the proton-coupled folate transporter.
    Desmoulin SK; Wang L; Polin L; White K; Kushner J; Stout M; Hou Z; Cherian C; Gangjee A; Matherly LH
    Mol Pharmacol; 2012 Oct; 82(4):591-600. PubMed ID: 22740639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of proton-coupled folate transporter in pemetrexed resistance of mesothelioma: clinical evidence and new pharmacological tools.
    Giovannetti E; Zucali PA; Assaraf YG; Funel N; Gemelli M; Stark M; Thunnissen E; Hou Z; Muller IB; Struys EA; Perrino M; Jansen G; Matherly LH; Peters GJ
    Ann Oncol; 2017 Nov; 28(11):2725-2732. PubMed ID: 28945836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The promise and challenges of exploiting the proton-coupled folate transporter for selective therapeutic targeting of cancer.
    Matherly LH; Hou Z; Gangjee A
    Cancer Chemother Pharmacol; 2018 Jan; 81(1):1-15. PubMed ID: 29127457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Reduced Folate Carrier (RFC) by Vitamin D Receptor at the Blood-Brain Barrier.
    Alam C; Hoque MT; Finnell RH; Goldman ID; Bendayan R
    Mol Pharm; 2017 Nov; 14(11):3848-3858. PubMed ID: 28885847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biology and therapeutic applications of the proton-coupled folate transporter.
    Matherly LH; Schneider M; Gangjee A; Hou Z
    Expert Opin Drug Metab Toxicol; 2022 Oct; 18(10):695-706. PubMed ID: 36239195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The proton-coupled folate transporter (PCFT-SLC46A1) and the syndrome of systemic and cerebral folate deficiency of infancy: Hereditary folate malabsorption.
    Zhao R; Aluri S; Goldman ID
    Mol Aspects Med; 2017 Feb; 53():57-72. PubMed ID: 27664775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Extrapolation of the Effects of Dolutegravir and Other HIV Integrase Inhibitors on Folate Transport Pathways.
    Zamek-Gliszczynski MJ; Zhang X; Mudunuru J; Du Y; Chen JL; Taskar KS; Huang J; Huang Y; Romach EH
    Drug Metab Dispos; 2019 Aug; 47(8):890-898. PubMed ID: 31167838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human reduced folate carrier: translation of basic biology to cancer etiology and therapy.
    Matherly LH; Hou Z; Deng Y
    Cancer Metastasis Rev; 2007 Mar; 26(1):111-28. PubMed ID: 17334909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for recognition and transport of folic acid in mammalian cells.
    Newstead S
    Curr Opin Struct Biol; 2022 Jun; 74():102353. PubMed ID: 35303537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual Targeting of Epithelial Ovarian Cancer Via Folate Receptor α and the Proton-Coupled Folate Transporter with 6-Substituted Pyrrolo[2,3-
    Hou Z; Gattoc L; O'Connor C; Yang S; Wallace-Povirk A; George C; Orr S; Polin L; White K; Kushner J; Morris RT; Gangjee A; Matherly LH
    Mol Cancer Ther; 2017 May; 16(5):819-830. PubMed ID: 28138029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Tyr residues that enhance folate substrate binding and constrain oscillation of the proton-coupled folate transporter (PCFT-SLC46A1).
    Visentin M; Unal ES; Najmi M; Fiser A; Zhao R; Goldman ID
    Am J Physiol Cell Physiol; 2015 Apr; 308(8):C631-41. PubMed ID: 25608532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.